Novo Nordisk Australasia
 

Novo Nordisk and Diabetes Care

In diabetes, our largest therapy area, Novo Nordisk - and the world at large - still faces many challenges. We are continuously striving to bring treatment to a larger proportion of the world and to develop new techniques and products to improve the lives of people with diabetes.

Novo Nordisk's broad range of diabetes products:

Novo Nordisk has the industry's broadest range of diabetes discovery and development projects.

Therefore, in addition to increasing our efforts to identify better pharmaceuticals, we are committed to promoting collaboration with all parties who share the common goal of defeating disease.

 

Haemostasis Management
The body normally forms a blood clot to stop bleeding. This process is known as haemostasis or coagulation. There are many medical conditions in which the blood fails to clot or coagulate normally. Many of these conditions are rare and require specialised medical care.

Growth Therapy
Visit our FAQs section to find out more about injecting growth hormone...

 

Hormone Therapy
Novo Nordisk is one of the world's leading manufacturers of hormone therapy (HT). For several decades, we have been at the forefront of developments and our products are used by women around the world.

We are continuing to develop products that can help women through every stage of the menopause.